Sponsor-study
Showing 1 - 25 of >10,000
Adult Onset Still's Disease Trial in Worldwide (AEVI-007 (CERC-007, AVTX-007))
Recruiting
- Adult Onset Still's Disease
- AEVI-007 (CERC-007, AVTX-007)
-
La Mesa, California
- +13 more
Aug 26, 2022
ACS - Acute Coronary Syndrome, NSTEMI - Non-ST Segment Elevation MI Trial in New York (Sponsor MCG device)
Recruiting
- ACS - Acute Coronary Syndrome
- NSTEMI - Non-ST Segment Elevation MI
- Sponsor MCG device
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 23, 2023
Healthy Subjects Trial in Suzhou ([14C]JT001)
Recruiting
- Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 4, 2023
Elderly Subjects With Underlying Diseases Trial in Shanghai (Deuremidevir Hydrobromide Tablets)
Completed
- Elderly Subjects With Underlying Diseases
- Deuremidevir Hydrobromide Tablets
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 16, 2023
Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Jacksonville, Saint Paul (XXB750, Placebo)
Recruiting
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- XXB750
- Placebo
-
Jacksonville, Florida
- +2 more
Jan 13, 2023
Healthy Volunteers Trial in Madison (RO7223280)
Recruiting
- Healthy Volunteers
-
Madison, WisconsinCovance Clinical Research Unit, Inc
Jan 9, 2023
Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)
Not yet recruiting
- Advanced Solid Tumor
- JS015
- +10 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 17, 2023
Health Volunteer Trial in Shenzhen (JS002)
Not yet recruiting
- Health Volunteer
-
Shenzhen, Guangdong, ChinaShenzhen Third People's Hospital
May 15, 2023
Advanced Malignant Tumor Trial in Jinan (JS207)
Not yet recruiting
- Advanced Malignant Tumor
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023
Subjects With Renal Impairment, Healthy Subjects Trial in Shanghai (Deuremidevir Hydrobromide Tablets)
Recruiting
- Subjects With Renal Impairment
- Healthy Subjects
- Deuremidevir Hydrobromide Tablets
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
May 29, 2023
Healthy Trial in New Haven (sisunatovir, , moxifloxacin)
Recruiting
- Healthy
- sisunatovir
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 18, 2023
Respiratory Syncytial Viruses Trial (sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Viruses
- sisunatovir
- Placebo
- (no location specified)
Jan 25, 2023
Healthy Participants Trial in New Haven (PF-06954522, Placebo)
Not yet recruiting
- Healthy Participants
- PF-06954522
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Aug 15, 2023
Healthy Participants Trial in Brussels (PF-07899895, Placebo)
Not yet recruiting
- Healthy Participants
- PF-07899895
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Nov 14, 2023
Advanced Solid Tumors Trial in Guangzhou (JS109 combine with irinotecan)
Recruiting
- Advanced Solid Tumors
- JS109 combine with irinotecan
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Apr 9, 2023
Subjects With Liver Function Injury, Normal Liver Function Subject Trial in Changchun (Deuremidevir Hydrobromide Tablets)
Completed
- Subjects With Liver Function Injury
- Normal Liver Function Subject
- Deuremidevir Hydrobromide Tablets
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University Ethics Committee
Oct 16, 2023
Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)
Recruiting
- Healthy Volunteers
- SIM0278 Injection/Placebo
-
Qingdao, China, Shandong, ChinaAffiliated Hospital of Qingdao University
Aug 31, 2023
Advanced Solid Tumors Trial in Beijing (WJB001)
Not yet recruiting
- Advanced Solid Tumors
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023